nir-ii fluorescent proteins (BioMimetic Therapeutics)
90
Structured Review
BioMimetic Therapeutics
nir-ii fluorescent proteins
Nir Ii Fluorescent Proteins, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nir-ii+fluorescent+proteins/nir+ii+fluorescent+proteins/pm40465963-267-20-21
Average 90 stars, based on 1 article reviews
Nir Ii Fluorescent Proteins, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nir-ii+fluorescent+proteins/nir+ii+fluorescent+proteins/pm40465963-267-20-21
Average 90 stars, based on 1 article reviews
nir-ii fluorescent proteins - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Nanoscale Rhodium(I) Based Metal–Organic Framework Demonstrating Intense NIR-II Luminescence for Bioimaging Article Snippet: [S5] Xu, J.; Zhu, N.; Du, Y.; Han, T.; Zheng, X.; Li, J.; Article Title: Nanoscale Rhodium(I) Based Metal-Organic Framework Demonstrating Intense NIR-II Luminescence for Bioimaging. Article Snippet: Although luminescent metal−organic frameworks (MOFs) have been widely reported, rare examples were found to emit in the second near-infrared (NIR-II, 1000−1700 nm) window.. In this work, two nanoscale rhodium(I)-based MOFs (Rh-1@SDS and Rh-1@DSPE-PEG) have been controllably constructed in the aqueous dispersions of sodium dodecyl sulfate (SDS) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-Nmethoxy-poly(ethylene glycol) (DSPE-PEG), wherein micelleand vesicle-like aggregates form, respectively, with high colloidal stability.. The vesicular dispersion of Rh-1@DSPE-PEG exhibits intense NIR-II luminescence at 1125 (1245, shoulder) nm. Article Title: Biomimetic NIR-II fluorescent proteins created from chemogenic protein-seeking dyes for multicolor deep-tissue bioimaging Article Snippet: Article Title: Differentiating Aggressive from Nonaggressive Prostate Cancer Using Unconjugated Contrast Agents. Article Snippet: Prostate cancer is one of the most common malignancies among men globally.. Early and accurate assessment of tumor aggressiveness is essential for guiding treatment decisions and improving patient outcomes.. With growing clinical interest in combining optical, ultrasound, and photoacoustic imaging approaches for cancer detection, we systematically investigated the cellular uptake of three multimodal contrast agents�indocyanine green (ICG), ICG-loaded nanobubbles (ICG-NBs), and ICGloaded microbubbles (ICG-MBs)�across prostate cancer cell lines with varying aggressiveness (PC-3M > PC-3 > DU-145 > LNCaP). |